Delisting risk
NDRA · NASDAQ · Medical - Diagnostics & Research

ENDRA Life Sciences

Developing radio-frequency thermoacoustic ultrasound for point-of-care liver-fat measurement.

$5.11
After-hours close+0.11 (+2.10%)
At close$5.01(−7.49%)
DateEstimateReportedSurprise
Nov 2026−$0.84
Aug 2026−$0.84−$0.63+25.0%
May 2026−$1.23−$1.09+11.4%
Mar 2026−$1.23−$3.26−165.0%
Nov 2025−$1.95−$1.75+10.3%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
Jun 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Dec 2015
Sep 2015
Jun 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 13, 2026−$0.84$100.0K
Aug 14, 2026−$0.84−$0.63+25.0%$100.0K
May 18, 2026−$1.23−$1.09+11.4%
Mar 31, 2026−$1.23−$3.26−165.0%$100.0K
Nov 14, 2025−$1.95−$1.75+10.3%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 14, 2025
May 15, 2025
Mar 31, 2025
Nov 15, 2024
Aug 14, 2024
May 14, 2024
Mar 28, 2024
Nov 14, 2023
Aug 14, 2023
May 15, 2023
Mar 14, 2023
Nov 14, 2022
Aug 15, 2022
May 12, 2022
Mar 30, 2022
Nov 15, 2021
Aug 12, 2021
May 17, 2021
Mar 25, 2021
Nov 16, 2020
Aug 14, 2020
May 14, 2020
Mar 26, 2020
Nov 13, 2019
Aug 8, 2019
May 14, 2019
Mar 11, 2019
Nov 5, 2018
Aug 13, 2018
May 15, 2018
Mar 20, 2018
Nov 14, 2017
Aug 7, 2017
Jun 21, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015
Sep 30, 2015
Jun 30, 2015